|
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: THRB |
Gene summary for THRB |
| Gene information | Species | Human | Gene symbol | THRB | Gene ID | 7068 |
| Gene name | thyroid hormone receptor beta | |
| Gene Alias | C-ERBA-2 | |
| Cytomap | 3p24.2 | |
| Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | F1D8N7 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 7068 | THRB | HTA11_3410_2000001011 | Human | Colorectum | AD | 1.52e-15 | -5.62e-01 | 0.0155 |
| 7068 | THRB | HTA11_2951_2000001011 | Human | Colorectum | AD | 9.37e-04 | -6.80e-01 | 0.0216 |
| 7068 | THRB | HTA11_347_2000001011 | Human | Colorectum | AD | 6.12e-15 | 7.90e-01 | -0.1954 |
| 7068 | THRB | HTA11_411_2000001011 | Human | Colorectum | SER | 3.46e-07 | 1.12e+00 | -0.2602 |
| 7068 | THRB | HTA11_83_2000001011 | Human | Colorectum | SER | 3.62e-07 | -6.33e-01 | -0.1526 |
| 7068 | THRB | HTA11_1391_2000001011 | Human | Colorectum | AD | 1.02e-10 | -5.36e-01 | -0.059 |
| 7068 | THRB | HTA11_546_2000001011 | Human | Colorectum | AD | 4.81e-03 | -5.12e-01 | -0.0842 |
| 7068 | THRB | HTA11_866_3004761011 | Human | Colorectum | AD | 5.75e-19 | -6.41e-01 | 0.096 |
| 7068 | THRB | HTA11_8622_2000001021 | Human | Colorectum | SER | 2.68e-04 | -6.55e-01 | 0.0528 |
| 7068 | THRB | HTA11_10623_2000001011 | Human | Colorectum | AD | 2.26e-02 | -5.12e-01 | -0.0177 |
| 7068 | THRB | HTA11_6801_2000001011 | Human | Colorectum | SER | 2.83e-03 | -6.80e-01 | 0.0171 |
| 7068 | THRB | HTA11_10711_2000001011 | Human | Colorectum | AD | 7.95e-10 | -6.06e-01 | 0.0338 |
| 7068 | THRB | HTA11_7696_3000711011 | Human | Colorectum | AD | 3.47e-22 | -6.55e-01 | 0.0674 |
| 7068 | THRB | HTA11_6818_2000001021 | Human | Colorectum | AD | 7.70e-04 | -4.38e-01 | 0.0588 |
| 7068 | THRB | HTA11_99999970781_79442 | Human | Colorectum | MSS | 9.10e-25 | -6.42e-01 | 0.294 |
| 7068 | THRB | HTA11_99999971662_82457 | Human | Colorectum | MSS | 9.00e-12 | -4.33e-01 | 0.3859 |
| 7068 | THRB | HTA11_99999973899_84307 | Human | Colorectum | MSS | 2.35e-07 | -6.47e-01 | 0.2585 |
| 7068 | THRB | HTA11_99999974143_84620 | Human | Colorectum | MSS | 5.28e-14 | -5.06e-01 | 0.3005 |
| 7068 | THRB | F007 | Human | Colorectum | FAP | 2.22e-07 | -5.15e-01 | 0.1176 |
| 7068 | THRB | A001-C-207 | Human | Colorectum | FAP | 3.78e-04 | -3.31e-01 | 0.1278 |
| Page: 1 2 3 4 5 6 |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD | ![]() |
| Colorectum | SER | ![]() |
| Colorectum | MSS | ![]() |
| Colorectum | MSI-H | ![]() |
| Colorectum | FAP | ![]() |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:0070997 | Colorectum | AD | neuron death | 114/3918 | 361/18723 | 1.13e-06 | 3.72e-05 | 114 |
| GO:0030522 | Colorectum | AD | intracellular receptor signaling pathway | 87/3918 | 265/18723 | 3.69e-06 | 1.03e-04 | 87 |
| GO:0009755 | Colorectum | AD | hormone-mediated signaling pathway | 64/3918 | 190/18723 | 2.78e-05 | 5.24e-04 | 64 |
| GO:0051402 | Colorectum | AD | neuron apoptotic process | 77/3918 | 246/18723 | 8.07e-05 | 1.28e-03 | 77 |
| GO:00709971 | Colorectum | SER | neuron death | 84/2897 | 361/18723 | 5.76e-05 | 1.35e-03 | 84 |
| GO:00097551 | Colorectum | SER | hormone-mediated signaling pathway | 49/2897 | 190/18723 | 1.54e-04 | 3.00e-03 | 49 |
| GO:00514021 | Colorectum | SER | neuron apoptotic process | 60/2897 | 246/18723 | 1.65e-04 | 3.13e-03 | 60 |
| GO:00305221 | Colorectum | SER | intracellular receptor signaling pathway | 63/2897 | 265/18723 | 2.47e-04 | 4.20e-03 | 63 |
| GO:00305222 | Colorectum | MSS | intracellular receptor signaling pathway | 84/3467 | 265/18723 | 1.47e-07 | 6.79e-06 | 84 |
| GO:00097552 | Colorectum | MSS | hormone-mediated signaling pathway | 63/3467 | 190/18723 | 9.26e-07 | 3.23e-05 | 63 |
| GO:00709972 | Colorectum | MSS | neuron death | 97/3467 | 361/18723 | 5.21e-05 | 9.31e-04 | 97 |
| GO:00514022 | Colorectum | MSS | neuron apoptotic process | 66/3467 | 246/18723 | 7.94e-04 | 8.36e-03 | 66 |
| GO:00305223 | Colorectum | FAP | intracellular receptor signaling pathway | 67/2622 | 265/18723 | 6.84e-07 | 3.28e-05 | 67 |
| GO:00097554 | Colorectum | FAP | hormone-mediated signaling pathway | 51/2622 | 190/18723 | 2.23e-06 | 8.87e-05 | 51 |
| GO:00709974 | Colorectum | FAP | neuron death | 81/2622 | 361/18723 | 8.35e-06 | 2.46e-04 | 81 |
| GO:00514024 | Colorectum | FAP | neuron apoptotic process | 55/2622 | 246/18723 | 2.42e-04 | 3.37e-03 | 55 |
| GO:0060428 | Colorectum | FAP | lung epithelium development | 12/2622 | 37/18723 | 3.43e-03 | 2.48e-02 | 12 |
| GO:0030323 | Colorectum | FAP | respiratory tube development | 39/2622 | 181/18723 | 3.60e-03 | 2.58e-02 | 39 |
| GO:0048593 | Colorectum | FAP | camera-type eye morphogenesis | 28/2622 | 120/18723 | 3.98e-03 | 2.76e-02 | 28 |
| GO:0030324 | Colorectum | FAP | lung development | 38/2622 | 177/18723 | 4.28e-03 | 2.93e-02 | 38 |
| Page: 1 2 3 4 5 |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| hsa04919 | Colorectum | AD | Thyroid hormone signaling pathway | 51/2092 | 121/8465 | 1.71e-05 | 1.73e-04 | 1.10e-04 | 51 |
| hsa049191 | Colorectum | AD | Thyroid hormone signaling pathway | 51/2092 | 121/8465 | 1.71e-05 | 1.73e-04 | 1.10e-04 | 51 |
| hsa049192 | Colorectum | SER | Thyroid hormone signaling pathway | 40/1580 | 121/8465 | 1.02e-04 | 1.06e-03 | 7.67e-04 | 40 |
| hsa049193 | Colorectum | SER | Thyroid hormone signaling pathway | 40/1580 | 121/8465 | 1.02e-04 | 1.06e-03 | 7.67e-04 | 40 |
| hsa049194 | Colorectum | MSS | Thyroid hormone signaling pathway | 46/1875 | 121/8465 | 5.04e-05 | 4.97e-04 | 3.05e-04 | 46 |
| hsa049195 | Colorectum | MSS | Thyroid hormone signaling pathway | 46/1875 | 121/8465 | 5.04e-05 | 4.97e-04 | 3.05e-04 | 46 |
| hsa049198 | Colorectum | FAP | Thyroid hormone signaling pathway | 41/1404 | 121/8465 | 2.28e-06 | 4.28e-05 | 2.60e-05 | 41 |
| hsa049199 | Colorectum | FAP | Thyroid hormone signaling pathway | 41/1404 | 121/8465 | 2.28e-06 | 4.28e-05 | 2.60e-05 | 41 |
| hsa0491910 | Colorectum | CRC | Thyroid hormone signaling pathway | 35/1091 | 121/8465 | 2.05e-06 | 6.85e-05 | 4.64e-05 | 35 |
| hsa0491911 | Colorectum | CRC | Thyroid hormone signaling pathway | 35/1091 | 121/8465 | 2.05e-06 | 6.85e-05 | 4.64e-05 | 35 |
| hsa0491912 | Liver | HCC | Thyroid hormone signaling pathway | 75/4020 | 121/8465 | 8.76e-04 | 3.38e-03 | 1.88e-03 | 75 |
| hsa0491913 | Liver | HCC | Thyroid hormone signaling pathway | 75/4020 | 121/8465 | 8.76e-04 | 3.38e-03 | 1.88e-03 | 75 |
| hsa0491914 | Lung | IAC | Thyroid hormone signaling pathway | 27/1053 | 121/8465 | 1.61e-03 | 9.49e-03 | 6.30e-03 | 27 |
| hsa0491915 | Lung | IAC | Thyroid hormone signaling pathway | 27/1053 | 121/8465 | 1.61e-03 | 9.49e-03 | 6.30e-03 | 27 |
| hsa0491921 | Lung | AIS | Thyroid hormone signaling pathway | 27/961 | 121/8465 | 3.92e-04 | 3.85e-03 | 2.47e-03 | 27 |
| hsa0491931 | Lung | AIS | Thyroid hormone signaling pathway | 27/961 | 121/8465 | 3.92e-04 | 3.85e-03 | 2.47e-03 | 27 |
| hsa0491941 | Lung | MIAC | Thyroid hormone signaling pathway | 16/507 | 121/8465 | 2.23e-03 | 2.03e-02 | 1.47e-02 | 16 |
| hsa0491951 | Lung | MIAC | Thyroid hormone signaling pathway | 16/507 | 121/8465 | 2.23e-03 | 2.03e-02 | 1.47e-02 | 16 |
| hsa0491924 | Prostate | BPH | Thyroid hormone signaling pathway | 39/1718 | 121/8465 | 1.27e-03 | 5.58e-03 | 3.45e-03 | 39 |
| hsa04919111 | Prostate | BPH | Thyroid hormone signaling pathway | 39/1718 | 121/8465 | 1.27e-03 | 5.58e-03 | 3.45e-03 | 39 |
| Page: 1 2 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 2 3 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| THRB | SNV | Missense_Mutation | novel | c.587N>T | p.Arg196Leu | p.R196L | P10828 | protein_coding | deleterious(0.04) | probably_damaging(0.994) | TCGA-EQ-8122-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Chemotherapy | 5-fluorouracil | SD |
| THRB | SNV | Missense_Mutation | c.1371N>C | p.Glu457Asp | p.E457D | P10828 | protein_coding | deleterious(0.02) | possibly_damaging(0.825) | TCGA-HU-A4GH-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
| THRB | SNV | Missense_Mutation | c.940N>C | p.Ser314Pro | p.S314P | P10828 | protein_coding | deleterious(0.01) | probably_damaging(0.996) | TCGA-HU-A4GU-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
| THRB | SNV | Missense_Mutation | novel | c.1229N>A | p.Arg410Gln | p.R410Q | P10828 | protein_coding | deleterious(0.03) | probably_damaging(0.994) | TCGA-KB-A93H-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
| THRB | insertion | Nonsense_Mutation | novel | c.149_150insGGACGCCTAGT | p.Asn51AspfsTer3 | p.N51Dfs*3 | P10828 | protein_coding | TCGA-FY-A4B0-01 | Thyroid | thyroid carcinoma | Male | >=65 | I/II | Hormone Therapy | synthroid | SD |
| Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| 7068 | THRB | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | LEVOTHYROXINE | LEVOTHYROXINE | ||
| 7068 | THRB | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | VK-2809 | |||
| 7068 | THRB | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | BENZO[D]ISOTHIAZOL-3-ONE | CHEMBL297304 | ||
| 7068 | THRB | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | (+)-THALIPORPHINE | CHEMBL1397308 | ||
| 7068 | THRB | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | ROSE BENGAL | ROSE BENGAL | ||
| 7068 | THRB | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | GNF-PF-321 | CHEMBL581044 | ||
| 7068 | THRB | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | 3-METHYLCHOLANTHRENE | 3-METHYLCHOLANTHRENE | ||
| 7068 | THRB | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | PROTOPORPHYRIN | PROTOPORPHYRIN | ||
| 7068 | THRB | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | ERYTHROSINE | ERYTHROSINE | ||
| 7068 | THRB | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | AMMONIA SOLUTION, STRONG | AMMONIA SOLUTION, STRONG | 22324546 |
| Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |